ロード中...
Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections
BACKGROUND: Chronic and recurrent bacterial diseases are recalcitrant to treatment due to the ability of the causative agents to establish biofilms, thus development of means to prevent or resolve these structures are greatly needed. Our approach targets the DNABII family of bacterial DNA-binding pr...
保存先:
| 出版年: | EBioMedicine |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7502671/ https://ncbi.nlm.nih.gov/pubmed/32651162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102867 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|